Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

HPLC-MS/MS measurement of lidocaine in rat skin and plasma. Application to study the release from medicated plaster.

Matteo C, Dovrtelova G, Di Clemente A, Frapolli R, Passoni A, Ceruti T, Marsella G, Cervo L, Zucchetti M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Feb 1;1138:121942. doi: 10.1016/j.jchromb.2019.121942. Epub 2019 Dec 18.

PMID:
31918305
2.

Monitoring the Fate of Orally Administered PLGA Nanoformulation for Local Delivery of Therapeutic Drugs.

Morelli L, Gimondi S, Sevieri M, Salvioni L, Guizzetti M, Colzani B, Palugan L, Foppoli A, Talamini L, Morosi L, Zucchetti M, Violatto MB, Russo L, Salmona M, Prosperi D, Colombo M, Bigini P.

Pharmaceutics. 2019 Dec 6;11(12). pii: E658. doi: 10.3390/pharmaceutics11120658.

3.

A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells.

Orienti I, Salvati V, Sette G, Zucchetti M, Bongiorno-Borbone L, Peschiaroli A, Zolla L, Francescangeli F, Ferrari M, Matteo C, Bello E, Di Virgilio A, Falchi M, De Angelis ML, Baiocchi M, Melino G, De Maria R, Zeuner A, Eramo A.

J Exp Clin Cancer Res. 2019 Aug 22;38(1):373. doi: 10.1186/s13046-019-1383-9.

4.

An ablation index operator-independent approach to improve efficacy in atrial fibrillation ablation at 24-month follow-up: a single center experience.

Casella M, Dello Russo A, Riva S, Catto V, Negro G, Sicuso R, Cellucci S, Gasperetti A, Zucchetti M, Ribatti V, Biagioli V, Fassini G, Di Biase L, Natale A, Tondo C.

J Interv Card Electrophysiol. 2019 Jul 16. doi: 10.1007/s10840-019-00587-y. [Epub ahead of print]

PMID:
31313089
5.

Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study.

Petrillo M, Zucchetti M, Cianci S, Morosi L, Ronsini C, Colombo A, D'Incalci M, Scambia G, Fagotti A.

J Gynecol Oncol. 2019 Jul;30(4):e59. doi: 10.3802/jgo.2019.30.e59. Epub 2019 Mar 1.

6.

Acute outcome after a single cryoballoon ablation: Comparison between Arctic Front Advance and Arctic Front Advance PRO.

Moltrasio M, Sicuso R, Fassini GM, Riva SI, Tundo F, Dello Russo A, Casella M, Majocchi B, Zucchetti M, Cellucci S, Tondo C.

Pacing Clin Electrophysiol. 2019 Jul;42(7):890-896. doi: 10.1111/pace.13718. Epub 2019 May 15.

PMID:
31046130
7.

A left atrial appendage closure combined procedure review: Past, present, and future perspectives.

Gasperetti A, Fassini G, Tundo F, Zucchetti M, Dessanai M, Tondo C.

J Cardiovasc Electrophysiol. 2019 Aug;30(8):1345-1351. doi: 10.1111/jce.13957. Epub 2019 May 15. Review.

PMID:
31042321
8.

Venetoclax penetrates in cerebrospinal fluid and may be effective in chronic lymphocytic leukemia with central nervous system involvement.

Reda G, Cassin R, Dovrtelova G, Matteo C, Giannotta J, D'Incalci M, Cortelezzi A, Zucchetti M.

Haematologica. 2019 May;104(5):e222-e223. doi: 10.3324/haematol.2018.213157. Epub 2019 Feb 14. No abstract available.

9.

Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study.

Rizzari C, Lanvers-Kaminsky C, Valsecchi MG, Ballerini A, Matteo C, Gerss J, Wuerthwein G, Silvestri D, Colombini A, Conter V, Biondi A, Schrappe M, Moericke A, Zimmermann M, von Stackelberg A, Linderkamp C, Frühwald MC, Legien S, Attarbaschi A, Reismüller B, Kasper D, Smisek P, Stary J, Vinti L, Barisone E, Parasole R, Micalizzi C, Zucchetti M, Boos J.

Haematologica. 2019 Sep;104(9):1812-1821. doi: 10.3324/haematol.2018.206433. Epub 2019 Jan 31.

10.

Lesion index: a novel guide in the path of successful pulmonary vein isolation.

Dello Russo A, Fassini GM, Casella M, Romanelli E, Pala S, Riva S, Catto V, Moltrasio M, Tundo F, Zucchetti M, Majocchi B, Dessanai MA, Pizzamiglio F, Vettor G, Ribatti V, Gasperetti A, Cellucci S, Negro G, Sicuso R, Carbucicchio C, Tondo C.

J Interv Card Electrophysiol. 2019 Jun;55(1):27-34. doi: 10.1007/s10840-018-0487-z. Epub 2018 Dec 4.

PMID:
30515625
11.

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.

Grignani G, D'Ambrosio L, Pignochino Y, Palmerini E, Zucchetti M, Boccone P, Aliberti S, Stacchiotti S, Bertulli R, Piana R, Miano S, Tolomeo F, Chiabotto G, Sangiolo D, Pisacane A, Dei Tos AP, Novara L, Bartolini A, Marchesi E, D'Incalci M, Bardelli A, Picci P, Ferrari S, Aglietta M.

Lancet Oncol. 2018 Oct;19(10):1360-1371. doi: 10.1016/S1470-2045(18)30438-8. Epub 2018 Sep 11.

PMID:
30217671
12.

Self-Assembling PCL-Based Nanoparticles as PTX Solubility Enhancer Excipients.

Capasso Palmiero U, Morosi L, Lupi M, Ponzo M, Frapolli R, Zucchetti M, Ubezio P, Morbidelli M, D'Incalci M, Bello E, Moscatelli D.

Macromol Biosci. 2018 Oct;18(10):e1800164. doi: 10.1002/mabi.201800164. Epub 2018 Jul 25.

PMID:
30047229
13.

X-Ray Exposure in Cardiac Electrophysiology: A Retrospective Analysis in 8150 Patients Over 7 Years of Activity in a Modern, Large-Volume Laboratory.

Casella M, Dello Russo A, Russo E, Catto V, Pizzamiglio F, Zucchetti M, Majocchi B, Riva S, Vettor G, Dessanai MA, Fassini G, Moltrasio M, Tundo F, Vignati C, Conti S, Bonomi A, Carbucicchio C, Di Biase L, Natale A, Tondo C.

J Am Heart Assoc. 2018 May 22;7(11). pii: e008233. doi: 10.1161/JAHA.117.008233.

14.

Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumab.

Bizzaro F, Falcetta F, D'Agostini E, Decio A, Minoli L, Erba E, Alessandro Peccatori F, Scanziani E, Colombo N, Zucchetti M, Bani MR, Ubezio P, Giavazzi R.

Int J Cancer. 2018 Nov 1;143(9):2187-2199. doi: 10.1002/ijc.31596. Epub 2018 Aug 7.

15.

Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells.

Mologni L, Costanza M, Sharma GG, Viltadi M, Massimino L, Citterio S, Purgante S, Raman H, Pirola A, Zucchetti M, Piazza R, Gambacorti-Passerini C.

Neoplasia. 2018 May;20(5):467-477. doi: 10.1016/j.neo.2018.02.009. Epub 2018 Mar 30.

16.

Readily prepared biodegradable nanoparticles to formulate poorly water soluble drugs improving their pharmacological properties: The example of trabectedin.

Capasso Palmiero U, Morosi L, Bello E, Ponzo M, Frapolli R, Matteo C, Ferrari M, Zucchetti M, Minoli L, De Maglie M, Romanelli P, Morbidelli M, D'Incalci M, Moscatelli D.

J Control Release. 2018 Apr 28;276:140-149. doi: 10.1016/j.jconrel.2018.03.005. Epub 2018 Mar 7.

PMID:
29524443
17.

Therapeutic Drug Monitoring of Asparaginase Activity-Method Comparison of MAAT and AHA Test Used in the International AIEOP-BFM ALL 2009 Trial.

Lanvers-Kaminsky C, Rüffer A, Würthwein G, Gerss J, Zucchetti M, Ballerini A, Attarbaschi A, Smisek P, Nath C, Lee S, Elitzur S, Zimmermann M, Möricke A, Schrappe M, Rizzari C, Boos J.

Ther Drug Monit. 2018 Feb;40(1):93-102. doi: 10.1097/FTD.0000000000000472.

PMID:
29210976
18.

Prompt detection of L-asparaginase inactivation is crucial to optimize treatment efficacy also in aggressive lymphomas.

Guolo F, Ferrari M, Minetto P, Matteo C, Clavio M, Coviello E, Ballerini F, Miglino M, Gobbi M, D'Incalci M, Lemoli RM, Zucchetti M.

Hematol Oncol. 2018 Apr;36(2):498-499. doi: 10.1002/hon.2484. Epub 2017 Oct 20. No abstract available.

PMID:
29052244
19.

Application of 3D Mass Spectrometry Imaging to TKIs.

Morosi L, Giordano S, Falcetta F, Frapolli R, Licandro SA, Matteo C, Zucchetti M, Ubezio P, Erba E, Visentin S, D'Incalci M, Davoli E.

Clin Pharmacol Ther. 2017 Nov;102(5):748-751. doi: 10.1002/cpt.786.

PMID:
29023728
20.

Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights.

Marmiroli P, Riva B, Pozzi E, Ballarini E, Lim D, Chiorazzi A, Meregalli C, Distasi C, Renn CL, Semperboni S, Morosi L, Ruffinatti FA, Zucchetti M, Dorsey SG, Cavaletti G, Genazzani A, Carozzi VA.

PLoS One. 2017 Oct 11;12(10):e0186250. doi: 10.1371/journal.pone.0186250. eCollection 2017.

21.

Bioreducible Hydrophobin-Stabilized Supraparticles for Selective Intracellular Release.

Maiolo D, Pigliacelli C, Sánchez Moreno P, Violatto MB, Talamini L, Tirotta I, Piccirillo R, Zucchetti M, Morosi L, Frapolli R, Candiani G, Bigini P, Metrangolo P, Baldelli Bombelli F.

ACS Nano. 2017 Sep 26;11(9):9413-9423. doi: 10.1021/acsnano.7b04979. Epub 2017 Aug 17.

22.

Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein.

Erba E, Romano M, Gobbi M, Zucchetti M, Ferrari M, Matteo C, Panini N, Colmegna B, Caratti G, Porcu L, Fruscio R, Perlangeli MV, Mezzanzanica D, Lorusso D, Raspagliesi F, D'Incalci M.

Biochem Pharmacol. 2017 Nov 15;144:52-62. doi: 10.1016/j.bcp.2017.08.001. Epub 2017 Aug 4.

PMID:
28782526
23.

Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations.

Ballerini A, Moro F, Nerini IF, Marzo CM, Di Clemente A, Ferrari M, D'Incalci M, Biondi A, Colombini A, Conter V, Porcu L, Cervo L, Rizzari C, Zucchetti M.

Cancer Chemother Pharmacol. 2017 Jun;79(6):1267-1271. doi: 10.1007/s00280-017-3307-8. Epub 2017 Apr 19.

PMID:
28424964
24.

A Nanostructured Matrices Assessment to Study Drug Distribution in Solid Tumor Tissues by Mass Spectrometry Imaging.

Giordano S, Pifferi V, Morosi L, Morelli M, Falciola L, Cappelletti G, Visentin S, Licandro SA, Frapolli R, Zucchetti M, Pastorelli R, Brunelli L, D'Incalci M, Davoli E.

Nanomaterials (Basel). 2017 Mar 21;7(3). pii: E71. doi: 10.3390/nano7030071.

25.

High Penetration of Paclitaxel in Abdominal Wall of Rabbits after Hyperthermic Intraperitoneal Administration of Nab-Paclitaxel Compared to Standard Paclitaxel Formulation.

Coccolini F, Acocella F, Morosi L, Brizzola S, Ghiringhelli M, Ceresoli M, Davoli E, Ansaloni L, D'Incalci M, Zucchetti M.

Pharm Res. 2017 Jun;34(6):1180-1186. doi: 10.1007/s11095-017-2132-4. Epub 2017 Feb 28.

PMID:
28247168
26.

Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging.

Giordano S, Zucchetti M, Decio A, Cesca M, Fuso Nerini I, Maiezza M, Ferrari M, Licandro SA, Frapolli R, Giavazzi R, Maurizio D, Davoli E, Morosi L.

Sci Rep. 2016 Dec 21;6:39284. doi: 10.1038/srep39284.

27.

In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models.

Guffanti F, Chilà R, Bello E, Zucchetti M, Zangarini M, Ceriani L, Ferrari M, Lupi M, Jacquet-Bescond A, Burbridge MF, Pierrat MJ, Damia G.

Neoplasia. 2017 Jan;19(1):35-42. doi: 10.1016/j.neo.2016.11.008. Epub 2016 Dec 15.

28.

Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy.

Iori V, Iyer AM, Ravizza T, Beltrame L, Paracchini L, Marchini S, Cerovic M, Hill C, Ferrari M, Zucchetti M, Molteni M, Rossetti C, Brambilla R, Steve White H, D'Incalci M, Aronica E, Vezzani A.

Neurobiol Dis. 2017 Mar;99:12-23. doi: 10.1016/j.nbd.2016.12.007. Epub 2016 Dec 9.

PMID:
27939857
29.

3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors.

Giordano S, Morosi L, Veglianese P, Licandro SA, Frapolli R, Zucchetti M, Cappelletti G, Falciola L, Pifferi V, Visentin S, D'Incalci M, Davoli E.

Sci Rep. 2016 Nov 14;6:37027. doi: 10.1038/srep37027.

30.

Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation.

Fassini G, Conti S, Moltrasio M, Maltagliati A, Tundo F, Riva S, Dello Russo A, Casella M, Majocchi B, Zucchetti M, Russo E, Marino V, Pepi M, Tondo C.

Europace. 2016 Nov;18(11):1705-1710. Epub 2016 Jul 11.

PMID:
27402623
31.

A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.

Zangrillo A, Alvaro G, Pisano A, Guarracino F, Lobreglio R, Bradic N, Lembo R, Gianni S, Calabrò MG, Likhvantsev V, Grigoryev E, Buscaglia G, Pala G, Auci E, Amantea B, Monaco F, De Vuono G, Corcione A, Galdieri N, Cariello C, Bove T, Fominskiy E, Auriemma S, Baiocchi M, Bianchi A, Frontini M, Paternoster G, Sangalli F, Wang CY, Zucchetti MC, Biondi-Zoccai G, Gemma M, Lipinski MJ, Lomivorotov VV, Landoni G.

Am Heart J. 2016 Jul;177:66-73. doi: 10.1016/j.ahj.2016.03.021. Epub 2016 Apr 23.

PMID:
27297851
32.

Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma.

Belli C, Piemonti L, D'Incalci M, Zucchetti M, Porcu L, Cappio S, Doglioni C, Allavena P, Ceraulo D, Maggiora P, Dugnani E, Cangi MG, Garassini G, Reni M.

Cancer Chemother Pharmacol. 2016 Mar;77(3):477-84. doi: 10.1007/s00280-015-2932-3. Epub 2015 Dec 14.

PMID:
26666646
33.

PEGylated Nanoparticles Obtained through Emulsion Polymerization as Paclitaxel Carriers.

Colombo C, Morosi L, Bello E, Ferrari R, Licandro SA, Lupi M, Ubezio P, Morbidelli M, Zucchetti M, D'Incalci M, Moscatelli D, Frapolli R.

Mol Pharm. 2016 Jan 4;13(1):40-6. doi: 10.1021/acs.molpharmaceut.5b00383. Epub 2015 Dec 11.

PMID:
26623665
34.

Near zerO fluoroscopic exPosure during catheter ablAtion of supRavenTricular arrhYthmias: the NO-PARTY multicentre randomized trial.

Casella M, Dello Russo A, Pelargonio G, Del Greco M, Zingarini G, Piacenti M, Di Cori A, Casula V, Marini M, Pizzamiglio F, Zucchetti M, Riva S, Russo E, Narducci ML, Soldati E, Panchetti L, Startari U, Bencardino G, Perna F, Santangeli P, Di Biase L, Cichocki F, Fattore G, Bongiorni M, Picano E, Natale A, Tondo C.

Europace. 2016 Oct;18(10):1565-1572. Epub 2015 Nov 10.

35.

Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response.

Cesca M, Morosi L, Berndt A, Fuso Nerini I, Frapolli R, Richter P, Decio A, Dirsch O, Micotti E, Giordano S, D'Incalci M, Davoli E, Zucchetti M, Giavazzi R.

Mol Cancer Ther. 2016 Jan;15(1):125-35. doi: 10.1158/1535-7163.MCT-15-0063. Epub 2015 Oct 22.

36.

Electrical storm: A clinical and electrophysiological overview.

Conti S, Pala S, Biagioli V, Del Giorno G, Zucchetti M, Russo E, Marino V, Dello Russo A, Casella M, Pizzamiglio F, Catto V, Tondo C, Carbucicchio C.

World J Cardiol. 2015 Sep 26;7(9):555-61. doi: 10.4330/wjc.v7.i9.555. Review.

37.

Difficult case of a trans-septal puncture: Use of a "SafeSept" guidewire.

Zucchetti M, Casella M, DelloRusso A, Fassini G, Carbucicchio C, Russo E, Marino V, Catto V, Tondo C.

World J Cardiol. 2015 Aug 26;7(8):499-503. doi: 10.4330/wjc.v7.i8.499.

38.

HPLC-MS/MS method to measure trabectedin in tumors: preliminary PK study in a mesothelioma xenograft model.

Ceriani L, Ferrari M, Zangarini M, Licandro SA, Bello E, Frapolli R, Falcetta F, D'Incalci M, Libener R, Grosso F, Aviles P, Zucchetti M.

Bioanalysis. 2015;7(15):1831-42. doi: 10.4155/bio.15.117.

PMID:
26295985
39.

Mortality in Multicenter Critical Care Trials: An Analysis of Interventions With a Significant Effect.

Landoni G, Comis M, Conte M, Finco G, Mucchetti M, Paternoster G, Pisano A, Ruggeri L, Alvaro G, Angelone M, Bergonzi PC, Bocchino S, Borghi G, Bove T, Buscaglia G, Cabrini L, Callegher L, Caramelli F, Colombo S, Corno L, Del Sarto P, Feltracco P, Forti A, Ganzaroli M, Greco M, Guarracino F, Lembo R, Lobreglio R, Meroni R, Monaco F, Musu M, Pala G, Pasin L, Pieri M, Pisarra S, Ponticelli G, Roasio A, Santini F, Silvetti S, Székely A, Zambon M, Zucchetti MC, Zangrillo A, Bellomo R.

Crit Care Med. 2015 Aug;43(8):1559-68. doi: 10.1097/CCM.0000000000000974.

PMID:
25821918
40.

Idiopathic Ventricular Tachycardia: Transcatheter Ablation or Antiarrhythmic Drugs?

Tondo C, Carbucicchio C, Russo AD, Majocchi B, Zucchetti M, Pizzamiglio F, Bologna F, Cattaneo F, Colombo D, Russo E, Casella M.

J Atr Fibrillation. 2015 Feb 28;7(5):1164. doi: 10.4022/jafib.1164. eCollection 2015 Feb-Mar.

41.

Right Ventricular Outflow Tract Arrhythmias: Benign Or Early Stage Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia?

Lin T, Conti S, Cipolletta L, Marino V, Zucchetti M, Russo E, Pizzamiglio F, AlMohani G, Pala S, Catto V, Biase LD, Natale A, Tondo C, Carbucicchio C.

J Atr Fibrillation. 2014 Dec 31;7(4):1161. doi: 10.4022/jafib.1161. eCollection 2014 Dec. Review.

42.

New Imaging Technologies To Characterize Arrhythmic Substrate.

Russo AD, Conti S, Al-Mohani G, Casella M, Pizzamiglio F, Carbucicchio C, Riva S, Fassini G, Moltrasio M, Tundo F, Zucchetti M, Majocchi B, Russo E, Marino V, Bologna F, Biase LD, Natale A, Tondo C.

J Atr Fibrillation. 2014 Dec 31;7(4):1137. doi: 10.4022/jafib.1137. eCollection 2014 Dec. Review.

43.

Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer.

Ansaloni L, Coccolini F, Morosi L, Ballerini A, Ceresoli M, Grosso G, Bertoli P, Busci LM, Lotti M, Cambria F, Pisano M, Rossetti D, Frigerio L, D'Incalci M, Zucchetti M.

Br J Cancer. 2015 Jan 20;112(2):306-12. doi: 10.1038/bjc.2014.602. Epub 2014 Dec 2.

44.

Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial.

Bove T, Zangrillo A, Guarracino F, Alvaro G, Persi B, Maglioni E, Galdieri N, Comis M, Caramelli F, Pasero DC, Pala G, Renzini M, Conte M, Paternoster G, Martinez B, Pinelli F, Frontini M, Zucchetti MC, Pappalardo F, Amantea B, Camata A, Pisano A, Verdecchia C, Dal Checco E, Cariello C, Faita L, Baldassarri R, Scandroglio AM, Saleh O, Lembo R, Calabrò MG, Bellomo R, Landoni G.

JAMA. 2014 Dec 3;312(21):2244-53. doi: 10.1001/jama.2014.13573.

PMID:
25265449
45.

Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors.

Soria JC, DeBraud F, Bahleda R, Adamo B, Andre F, Dienstmann R, Delmonte A, Cereda R, Isaacson J, Litten J, Allen A, Dubois F, Saba C, Robert R, D'Incalci M, Zucchetti M, Camboni MG, Tabernero J.

Ann Oncol. 2014 Nov;25(11):2244-51. doi: 10.1093/annonc/mdu390. Epub 2014 Sep 5. Erratum in: Ann Oncol. 2015 Feb;26(2):445. Dientsmann, R [corrected to Dienstmann, R].

46.

The Growing Culture Of A Minimally Fluoroscopic Approach In Electrophysiology Lab.

Casella M, Russo E, Pizzamiglio F, Conti S, Al-Mohani G, Colombo D, Casula V, D Alessandra Y, Biagioli V, Carbucicchio C, Riva S, Fassini G, Moltrasio M, Tundo F, Zucchetti M, Majocchi B, Marino V, Forleo G, Santangeli P, Di Biase L, Dello Russo A, Natale A, Tondo C.

J Atr Fibrillation. 2014 Aug 31;7(2):1104. doi: 10.4022/jafib.1104. eCollection 2014 Aug-Sep. Review.

47.

New class of squalene-based releasable nanoassemblies of paclitaxel, podophyllotoxin, camptothecin and epothilone A.

Borrelli S, Christodoulou MS, Ficarra I, Silvani A, Cappelletti G, Cartelli D, Damia G, Ricci F, Zucchetti M, Dosio F, Passarella D.

Eur J Med Chem. 2014 Oct 6;85:179-90. doi: 10.1016/j.ejmech.2014.07.035. Epub 2014 Jul 27.

PMID:
25084144
48.

Intratumor heterogeneity and its impact on drug distribution and sensitivity.

Fuso Nerini I, Morosi L, Zucchetti M, Ballerini A, Giavazzi R, D'Incalci M.

Clin Pharmacol Ther. 2014 Aug;96(2):224-38. doi: 10.1038/clpt.2014.105. Epub 2014 May 14. Review.

PMID:
24827540
49.

Phase ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targets.

Toffalorio F, Spitaleri G, Catania C, Dal Zotto L, Noberasco C, Delmonte A, Santarpia M, Vecchio F, Brunelli V, Rampinelli C, Barberis M, Fumagalli C, Zucchetti M, Zangarini M, Diena T, Danesi R, de Braud F, De Pas T.

Oncologist. 2014 Apr;19(4):344-5. doi: 10.1634/theoncologist.2013-0335. Epub 2014 Mar 27.

50.

Quantification of trabectedin in human plasma: validation of a high-performance liquid chromatography-mass spectrometry method and its application in a clinical pharmacokinetic study.

Zangarini M, Ceriani L, Sala F, Marangon E, Bagnati R, D'Incalci M, Grosso F, Zucchetti M.

J Pharm Biomed Anal. 2014 Jul;95:107-12. doi: 10.1016/j.jpba.2014.02.018. Epub 2014 Mar 2.

PMID:
24662672

Supplemental Content

Loading ...
Support Center